Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by Sniper007on Aug 14, 2020 3:09pm
180 Views
Post# 31410119

RE:RE:RE:RE:RE:RE: "excellent" progress on early-stage pipeline

RE:RE:RE:RE:RE:RE: "excellent" progress on early-stage pipeline"Another option would be to become a trust bank so to speak, were all Pharma's can license our technology but never acquire it.  We would become a perpetual licensing machine."
Agreed hcontrol. That's what I was eluding to when I said we become "the dealer".
Whether it's realistic or not, it scares me to think of only 1 pharma owning the technology. It could then be about money, greed and ego rather than improving the lives of so many suffering from awful diseases. In many ways I feel Bioasis has responsibility to license the technology rather than selling it. That said, I wouldn't be opposed to selling 001 for a billion!
We're sitting on a lottery ticket but we have to get on the Nasdaq first which is going to require additional licensing deals!
Get 'er done DrDR!
<< Previous
Bullboard Posts
Next >>